Drug Development

Research into Cold Cancers Heating Up

Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.

Development of Gamma-Delta T-Cell Therapies

Activation and expansion are essential for success in both autologous and allogeneic therapies.

QbD for Small-Molecule Continuous Process Development

Continuous manufacturing and a quality-by-design development approach are a natural fit.

Six Approaches Making the Most Significant Impact in the Future

January 03, 2023

This compilation allows readers to adjust their thinking to appreciate the full impact certain select technologies will make on the industry by 2026.

Inhalation Vaccine Development

January 03, 2023

Inhaled vaccines must resist degradation and penetrate the mucosal lining in the airways and lungs.

Paradigm Shift

January 02, 2023

Cell and gene therapies is unequivocally viewed as the biggest opportunity in the bio/pharma space.

Sosei Heptares and Eli Lilly Enter Multi-target Collaboration

December 20, 2022

Sosei Heptares and Eli Lilly have entered a multi-target collaboration and license agreement in diabetes and metabolic diseases.

Drug Solutions Podcast: Outsourcing vs. Insourcing in Biopharma: Determining the Best Strategy: Part 2

December 20, 2022

In this episode of the Drug Solutions Podcast, Meg Rivers discusses outsourcing strategies in biopharma with Jeff Henderson, key account manager of Vetter.

GSK and Wave Life Sciences to Collaborate on Oligonucleotide Therapeutics

December 19, 2022

GSK and Wave Life Sciences have entered into a collaboration to drive drug discovery and development for novel genetic targets.

AbCellera and Rallybio Partner on Novel Antibody-Based Therapeutics

December 19, 2022

AbCellera and Rallybio are teaming up to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases.

Emmes Launches Cell and Gene Therapy Center

December 14, 2022

Emmes’ new facility is designed to support clients conducting cell and gene therapy research worldwide.

Generate Biomedicines Uses AI to Create Proteins That Have Never Existed

December 12, 2022

Generate Biomedicines published a preprint describing technology that can generate novel proteins towards desired functional or other properties.

Drug Solutions Podcast: FDA Quality Management Maturity (QMM) Overseas Pilot Program Findings: Going Beyond the Regulations

December 07, 2022

In this episode of the Drug Solutions Podcast, Chris Spivey interviews executives at Shabas Solutions LLC, who ran the overseas QMM pilot project.